_version_ 1783687949106282496
author Maia, Catarina
Martín-Sánchez, Esperanza
Garcés, Juan José
de Cerio, Ascensión López-Díaz
Inogés, Susana
Landecho, Manuel F.
Gil-Alzugaray, Belén
Perez, Cristina
Botta, Cirino
Zabaleta, Aintzane
Alegre, Félix
Rincón, César
Blanco, Laura
Sarvide, Sarai
Vilas-Zornoza, Amaia
Alignani, Diego
Moreno, Cristina
Paiva, Artur
Martinho, António
Alves, Rui
Colado, Enrique
Quirós, Covadonga
Olid, Mónica
Blanco, Andrés
Argemi, Josepmaria
Paiva, Bruno
Yuste, José Ramón
author_facet Maia, Catarina
Martín-Sánchez, Esperanza
Garcés, Juan José
de Cerio, Ascensión López-Díaz
Inogés, Susana
Landecho, Manuel F.
Gil-Alzugaray, Belén
Perez, Cristina
Botta, Cirino
Zabaleta, Aintzane
Alegre, Félix
Rincón, César
Blanco, Laura
Sarvide, Sarai
Vilas-Zornoza, Amaia
Alignani, Diego
Moreno, Cristina
Paiva, Artur
Martinho, António
Alves, Rui
Colado, Enrique
Quirós, Covadonga
Olid, Mónica
Blanco, Andrés
Argemi, Josepmaria
Paiva, Bruno
Yuste, José Ramón
author_sort Maia, Catarina
collection PubMed
description
format Online
Article
Text
id pubmed-8094106
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-80941062021-05-06 Immunologic characterization of COVID-19 patients with hematological cancer Maia, Catarina Martín-Sánchez, Esperanza Garcés, Juan José de Cerio, Ascensión López-Díaz Inogés, Susana Landecho, Manuel F. Gil-Alzugaray, Belén Perez, Cristina Botta, Cirino Zabaleta, Aintzane Alegre, Félix Rincón, César Blanco, Laura Sarvide, Sarai Vilas-Zornoza, Amaia Alignani, Diego Moreno, Cristina Paiva, Artur Martinho, António Alves, Rui Colado, Enrique Quirós, Covadonga Olid, Mónica Blanco, Andrés Argemi, Josepmaria Paiva, Bruno Yuste, José Ramón Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-12-17 /pmc/articles/PMC8094106/ /pubmed/33327714 http://dx.doi.org/10.3324/haematol.2020.269878 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Maia, Catarina
Martín-Sánchez, Esperanza
Garcés, Juan José
de Cerio, Ascensión López-Díaz
Inogés, Susana
Landecho, Manuel F.
Gil-Alzugaray, Belén
Perez, Cristina
Botta, Cirino
Zabaleta, Aintzane
Alegre, Félix
Rincón, César
Blanco, Laura
Sarvide, Sarai
Vilas-Zornoza, Amaia
Alignani, Diego
Moreno, Cristina
Paiva, Artur
Martinho, António
Alves, Rui
Colado, Enrique
Quirós, Covadonga
Olid, Mónica
Blanco, Andrés
Argemi, Josepmaria
Paiva, Bruno
Yuste, José Ramón
Immunologic characterization of COVID-19 patients with hematological cancer
title Immunologic characterization of COVID-19 patients with hematological cancer
title_full Immunologic characterization of COVID-19 patients with hematological cancer
title_fullStr Immunologic characterization of COVID-19 patients with hematological cancer
title_full_unstemmed Immunologic characterization of COVID-19 patients with hematological cancer
title_short Immunologic characterization of COVID-19 patients with hematological cancer
title_sort immunologic characterization of covid-19 patients with hematological cancer
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094106/
https://www.ncbi.nlm.nih.gov/pubmed/33327714
http://dx.doi.org/10.3324/haematol.2020.269878
work_keys_str_mv AT maiacatarina immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT martinsanchezesperanza immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT garcesjuanjose immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT decerioascensionlopezdiaz immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT inogessusana immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT landechomanuelf immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT gilalzugaraybelen immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT perezcristina immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT bottacirino immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT zabaletaaintzane immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT alegrefelix immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT rinconcesar immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT blancolaura immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT sarvidesarai immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT vilaszornozaamaia immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT alignanidiego immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT morenocristina immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT paivaartur immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT martinhoantonio immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT alvesrui immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT coladoenrique immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT quiroscovadonga immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT olidmonica immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT blancoandres immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT argemijosepmaria immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT paivabruno immunologiccharacterizationofcovid19patientswithhematologicalcancer
AT yustejoseramon immunologiccharacterizationofcovid19patientswithhematologicalcancer